[1] |
LI Min, LI Chunlei, SUN Cuicui, YU Wenwen, SUN Qing, QI Yingmei, LIU Anchang.
One Case of Acute Generalized Exanthematous Pustulosis Caused by Abrocitinib Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 823-825.
|
[2] |
ZHANG Meiwei, LI Keqian, YAO Keyu, ZHU Yan.
Current Descriptions of Functions in Package Inserts of Chinese Herbal Patent Medicines
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 193-196.
|
[3] |
JI Qiuxia, JIN Jian, ZHANG Bin.
Pharmaceutical care for immune-related adverse events induced by toripalimab
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 346-348.
|
[4] |
GUO Yijun, CHEN Xia, MENG Ping.
Adverse drug reaction reports in 141 cases of orally administered targeted anti-tumor drugs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1137-1142.
|
[5] |
XIONG Weiyi, REN Jingtian.
Considerations for revision of safety information in package inserts of anti-cancer drugs in post-market phase
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 94-97.
|
[6] |
HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia.
535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.
|
[7] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
[8] |
XIAO Wangzhong, LIN Cong, HUANG Li, DAI Bing, GAO Yuanfeng.
Contraindications in package inserts of Chinese patent medicine
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 400-403.
|
[9] |
LYU Tianyi, KUANG Li, CHEN Mingying.
Analysis of 1073 Cases of Clinical Use of Reduning Injection by Pareto Chart and Fishbone Diagram
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 745-748.
|
[10] |
ZHAO Shuang, SONG Yanqing, WANG Xiangfeng, JINFang, MIAO Qiuli.
Analysis of Pediatric Use Information in Package Inserts of Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 555-560.
|
[11] |
XU Shungui.
105 Cases of Adverse Drug Reactions Indcued by Ibuprofen in Our Hosptial
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 164-167.
|
[12] |
LIU Chen, CHU Yanqi, YAN Suying, JIN Chao, LIU Tong, XING Liqiu, ZHANG Xiao.
Analysis of 93 Reports of Adverse Drug Reactions Induced by Edaravone Injection
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 174-178.
|
[13] |
ZHAO Cui-hong, TAO Yi-xiu, WANG Sheng-hai, ZHAO Qiang, MENG Qing-yong, ZHANG Han-xiang, QING Ming-ying, MA Wen-xia, MI Man.
Study on Related Factors of Postoperative Nausea and Vomiting and Clinical Intervention in Patients with Intraspinal Anesthesia
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(4): 201-204.
|
[14] |
ZHAO Rui, CUI Xiangli, LIU Lihong.
Pharmaceutical Care of a Patient with Hydroxychloroquine Induced Long QT Syndrome
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 690-692.
|
[15] |
WANG Lin, LI Shuang, LI Hua-bin, JU Yong-jing.
Analysis of Adverse Drug Reactions about 141 Cases of Dextran 40 and Amino Acids Injection
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(1): 45-48.
|